Treatment of Heart Disease with an Intraventricular Sac

Printer-friendly version

Award Information

Agency:

Department of Health and Human Services

Branch:

N/A

Amount:

$94,624.00

Award Year:

2004

Program:

SBIR

Phase:

Phase I

Contract:

1R44HL078071-01

Agency Tracking Number:

HL078071

Solicitation Year:

2004

Solicitation Topic Code:

N/A

Solicitation Number:

PHS2004-2

Small Business Information

MC3, INC.

MC3, INC., 3550 W LIBERTY RD, STE 3, ANN ARBOR, MI, 48103

Hubzone Owned:

Socially and Economically Disadvantaged:

Woman Owned:

Duns:

N/A

Principal Investigator

Name: SEAN Chambers
Phone: (734) 995-9089
Email: schambers@mc3corp.com

Business Contact

Name: SCOTT MERZ
Phone: (734) 995-9089
Email: MERZ@MC3CORP.COM

Research Institution

N/A

Abstract

DESCRIPTION (provided by applicant): The purpose of this project is to develop a diastolic volume limiting apparatus (divola) for treatment of advanced heart disease in humans. This technology is an entirely new method of treatment of heart disease, and m

* information listed above is at the time of submission.

Treatment of Heart Disease with an Intraventricular Sac

Agency Micro-sites